We are live on
!
Find out more
KIC
Kensington Investment Counsel Portfolio holdings
AUM
$208M
1-Year Est. Return
11.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.84%
1 Year Est. Return
+11.99%
3 Year Est. Return
+61.57%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
-$20.4M
(-12%)
Cap. Flow
-$5.22M
Cap. Flow
% of AUM
-3.45%
Top 10 Holdings %
Top 10 Hldgs %
26.23%
Holding
91
New
3
Increased
46
Reduced
35
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Littelfuse
LFUS
|
+$1.2M |
| 2 |
Markel Group
MKL
|
+$561K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$458K |
| 4 |
Clorox
CLX
|
+$429K |
| 5 |
Amazon
AMZN
|
+$337K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$2.17M |
| 2 |
Jack Henry & Associates
JKHY
|
+$1.28M |
| 3 |
Bio-Techne
TECH
|
+$1.02M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$924K |
| 5 |
West Pharmaceutical
WST
|
+$895K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.32% |
| 2 | Financials | 17.6% |
| 3 | Healthcare | 17.22% |
| 4 | Industrials | 10.53% |
| 5 | Consumer Staples | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fidelity National Information Services
FIS
$21.6B
| $698K | 0.46% |
6,955
-90
| -1% | -$9.41K |
|
|
CFLT
77
DELISTED
Confluent
CFLT
| $690K | 0.46% |
16,825
-1,215
| -7% | -$63.3K |
|
|
78
West Pharmaceutical
WST
$24.8B
| $688K | 0.46% |
1,675
-2,286
| -58% | -$895K |
|
79
iShares Russell 2000 Value ETF
IWN
$14.6B
| $577K | 0.38% |
3,574
-453
| -11% | -$72.2K |
|
|
CERN
80
DELISTED
Cerner Corp
CERN
| $540K | 0.36% |
5,771
+88
| +2% | +$8.15K |
|
|
81
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $464K | 0.31% |
+1,028
| New | +$458K |
|
82
Meta Platforms (Facebook)
META
$1.47T
| $421K | 0.28% |
1,892
+220
| +13% | +$55K |
|
83
Quest Diagnostics
DGX
$26.2B
| $419K | 0.28% |
3,065
| – | – |
|
84
Costco
COST
$421B
| $347K | 0.23% |
603
| – | – |
|
|
UMH
85
UMH Properties
UMH
$1.39B
| $270K | 0.18% |
+11,000
| New | +$264K |
|
|
CNCE
86
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $259K | 0.17% |
76,749
-8,734
| -10% | -$27.7K |
|
87
Chubb
CB
$132B
| $255K | 0.17% |
1,190
| – | – |
|
|
88
Jack Henry & Associates
JKHY
$10.8B
| – | – |
-7,663
| Closed | -$1.28M |
|
89
Stryker
SYK
$133B
| – | – |
-1,000
| Closed | -$267K |
|
|
90
Tandem Diabetes Care
TNDM
$1.63B
| – | – |
-14,403
| Closed | -$2.17M |
|
|
AXNX
91
DELISTED
Axonics, Inc. Common Stock
AXNX
| – | – |
-16,504
| Closed | -$924K |
|
Similar funds
HCA
FHWM
SNBOSD
MIP
SG
MPCG
EPG
CC
Kensington Investment Counsel's Q1 2022 Portfolio in Review
As of Q1 2022, Kensington Investment Counsel held 91 positions worth $151M, down 12% from $172M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Kensington Investment Counsel withdrew a net $5.22M in Q1 2022, closing 4 positions and reducing 35 holdings. Its most notable exit was Tandem Diabetes Care, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Kensington Investment Counsel opened a new position in Littelfuse worth $1.13M.
- Kensington Investment Counsel's largest Q1 2022 buy was Littelfuse: 4,529 shares worth $1.13M.
- Kensington Investment Counsel added most to Markel Group in Q1 2022, an estimated $561K increase.
- Kensington Investment Counsel's biggest Q1 2022 reduction was Bio-Techne, cutting an estimated $1.02M.
- Kensington Investment Counsel fully exited Tandem Diabetes Care in Q1 2022, selling an estimated $2.17M.
- Kensington Investment Counsel's ten largest holdings make up 26% of its $151M portfolio in Q1 2022.
- Kensington Investment Counsel opened 3 new positions and closed 4 in Q1 2022.
- Kensington Investment Counsel's portfolio value fell 12% quarter-over-quarter to $151M.
Based on Kensington Investment Counsel's 13F filing for Q1 2022, filed 13 May 2022.